Complimentary Registration Available to Science and Innovation Forum on Platelet Bacterial Risk Control Strategies

August 31, 2021

Complimentary registration is available to an upcoming Science & Innovation Forum presented by Cerus Corporation that will explore strategies to meet the Food and Drug Administration’s compliance deadline for platelet bacterial risk control strategies. The program will take place at 2 p.m. ET on Thursday, Sept. 9. Registration is complimentary but required to attend.

In this program, Sandra Ramirez-Arcos, BSc, MSc, PhD, senior scientist at Canadian Blood Services; and Pampee P. Young, MD, PhD, chief medical officer, Biomedical Services, at the American Red Cross, will discuss their experiences with the use of anaerobic culture. The program is designed to provide insight for blood centers that are assessing guidance options.

Additionally, Rita Reik, MD, FCAP, chief medical officer at OneBlood, will share the organization’s approach to complying with FDA guidance, including the rationale for pathogen reducing the majority of OneBlood’s platelet inventory. The program will also explore blood safety, availability, and operational aspects from the perspective of both the blood center and transfusion services.